CST Biosciences Trademark Details
Word Mark | Cst Biosciences |
---|---|
Status | Alive 731 — Second Extension - Granted |
Current Owner
Cell Signaling Technology, Inc. of Danvers, MA
View all trademarks for Cell Signaling Technology, Inc.Serial Number | 86119908 |
---|---|
Status Date | Monday, September 12, 2016 |
Filing Date | Monday, September 12, 2016 |
Attorney | Steven A. Abreu |
Correspondent
STEVEN A. ABREU
SUNSTEIN KANN MURPHY & TIMBERS LLP
125 SUMMER ST
BOSTON, MA 02110-1618
SUNSTEIN KANN MURPHY & TIMBERS LLP
125 SUMMER ST
BOSTON, MA 02110-1618
Case File Statements
Disclaimer with Predetermined Text | "Biosciences" |
---|---|
Goods & Services | Antibodies, enzymes and nucleic acids for scientific and research use; Antibodies for the detection of signaling molecules, post-translational modifications on signaling molecules, non-radioactive kinase and other enzyme assays, kinase and other enzyme inhibitors designed for use in biotechnological and biomedical research; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic kits consisting of reagents for scientific or research use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; reagents for use in the development of therapeutic substances; reagents for research purposes; reagents for use in scientific apparatus for chemical and biological analysis |
Goods & Services | Diagnostic kits consisting of reagents for therapeutic use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic reagents and contrast media for medical use; diagnostic reagents for therapeutic use; diagnostic reagents for medicinal use; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; medical diagnostic reagents |
Goods & Services | Biological research in the field of proteomics and cellular signal transduction; consulting services in the fields of biotechnology, pharmaceutical research and developments, laboratory testing, diagnostics and pharmacogenetics; custom design and development of chemical reagents and biochemical assays for others; diagnostic services in the field of proteomics and cellular signal transduction; providing reagent sample testing and diagnostic services for others in the fields of science and scientific research |
Pseudo Mark | Cell Signaling Technology Biosciences |
Classifications
International Class Codes |
001
|
---|---|
U.S. Class Codes | 001, 005, 006, 010, 026, 046 |
Status | 6 — Active |
Status Date | Saturday, November 30, 2013 |
Primary Code | 001 |
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Saturday, November 30, 2013 |
Primary Code | 005 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Saturday, November 30, 2013 |
Primary Code | 042 |
Trademark Timeline
-
Nov 15 2013Trademark application filed with USPTO
-
Nov 19 2013New Application Entered In Tram
-
Nov 30 2013New Application Office Supplied Data Entered In Tram
-
Dec 03 2013Notice of Pseudo Mark E-Mailed
-
Mar 03 2014Assigned To Examiner
-
Mar 10 2014Notification of Examiners Amendment E-Mailed
-
Mar 10 2014Examiners Amendment E-Mailed
-
Mar 10 2014Examiners Amendment -Written
-
Mar 11 2014Assigned To Lie
-
Mar 11 2014Examiner's Amendment Entered
-
Apr 01 2014Previous Allowance Count Withdrawn
-
Apr 01 2014Approved For Pub - Principal Register
-
May 05 2014Notification of Non-Final Action E-Mailed
-
May 05 2014Non-Final Action E-Mailed
-
May 05 2014Non-Final Action Written
-
May 07 2014International filing request made
-
May 07 2014New Application For Ir Received
-
May 08 2014Manually Certified
-
May 08 2014Ir Certified and Sent To Ib
-
Oct 16 2014Application For Ir Registered By Ib
-
Nov 05 2014Teas/email Correspondence Entered
-
Nov 05 2014Correspondence Received In Law Office
-
Nov 05 2014Teas Response To Office Action Received
-
Dec 01 2014Notification of Final Refusal Emailed
-
Dec 01 2014Final Refusal E-Mailed
-
Dec 01 2014Final Refusal Written
-
May 01 2015Teas Request For Reconsideration Received
-
May 07 2015Teas/email Correspondence Entered
-
May 07 2015Correspondence Received In Law Office
-
May 13 2015Approved For Pub - Principal Register
-
May 16 2015Law Office Publication Review Completed
-
Jun 03 2015Notification of Notice of Publication E-Mailed
-
Jun 23 2015Official Gazette Publication Confirmation E-Mailed
-
Jun 23 2015Published For Opposition
-
Aug 18 2015Noa E-Mailed - Sou Required From Applicant
-
Jan 25 2016Extension 1 Granted
-
Jan 25 2016Extension 1 Filed
-
Jan 25 2016Teas Extension Received
-
Jan 27 2016Notice of Approval of Extension Request E-Mailed
-
Aug 18 2016Extension 2 Filed
-
Aug 18 2016Teas Extension Received
-
Sep 09 2016Case Assigned To Intent To Use Paralegal
-
Sep 12 2016Extension 2 Granted
-
Sep 13 2016Notice of Approval of Extension Request E-Mailed